Alkem to launch state-of-the-art technology to treat DFU in India
Category: #tech  By Mateen Dalal  Date: 2022-01-13
  • share
  • Twitter
  • Facebook
  • LinkedIn

Alkem to launch state-of-the-art technology to treat DFU in India

Alkem Laboratories Ltd. (Alkem), an Indian multinational pharmaceutical company, has reportedly launched a unique patented technology for the treatment of Diabetic Foot Ulcer (DFU) in India.

The solution would be based on an innovative technology of 4D Bioprinting, which would be used for treating non-healing, deep chronic wounds and is estimated to be launched in the second half of 2022 in the Indian market after receiving the regulatory approvals.

This cutting-edge technology for DFU management possesses high scope of averting amputations in diabetic patients. This technology will be obtainable at reasonable rates to the patients of India at a time when no decisive treatment of DFU is there in India.

At present, India has around 77 million diabetic patients, ranking it to be 2nd highest in the world. DFU (Diabetic foot ulcer) is one of the most common and disturbing complications of diabetes and is restricted as a foot affected by ulceration linked with neuropathy and peripheral arterial disease of the lower limb in a diabetic patient.

Moreover, around 12-15% of diabetic people suffer from DFU at least once in their whole lifetime. 5-24% of this population will finally lead to limb amputation within 6–18 months after the first assessment. The risks of getting limb amputation and foot ulceration increases in contrast to the age and duration of diabetes.

Imperatively, Alkem and Rokit Healthcare Inc. have collaborated to commercialize the technology in India to reduce amputation amongst DFU patients considering the adverse impact of amputation on the quality of patient’s life and the linked economic burden on the healthcare system.

Mr. Sandeep Singh, Managing Director, Alkem Laboratories Ltd., stated that diabetes is one of the major challenges faced by the healthcare systems in India. The challenge is so massive that diabetic foot ulcers get ignored very often. To address these issues, Alkem and Rokit Healthcare INC have collaborated to bring out a new solution for managing diabetic foot ulcers, Sandeep cited.

Source Credit - https://www.prnewswire.com/in/news-releases/alkem-laboratories-ltd-to-launch-state-of-the-art-technology-for-diabetic-foot-ulcer-management-for-the-first-time-in-india-838015097.html

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Saepio, Echoworx partner to deliver Next-Gen security solutions
Saepio, Echoworx partner to deliver Next-Gen security solutions
By Mateen Dalal

Saepio Information Security, a market leader in statement encryption and cloud-based email, has reportedly announced its collaboration with Echoworx to offer next-generation safe delivery of sensitive and secret information to any email receiver...

Ather Energy raises $250 million to stay ahead in competition
Ather Energy raises $250 million to stay ahead in competition
By Mateen Dalal

Electric scooter producer Ather Energy has reportedly secured $250 million in a new funding round. As per reports, the investment round is in its early stages. The company’s goal is to obtain $200 million to $250 million to compete in the EV...

Digital wellness startup Mojorcare bags USD 20 Mn in Series A funding
Digital wellness startup Mojorcare bags USD 20 Mn in Series A funding
By Mateen Dalal

Mojocare, a wellness and health startup has reportedly raised USD 20.6 million in a Series A round of funding which was led by B Capital Group and saw participation from existing investors including Sequoia India’s Surge, Better Capital, and Ch...